AstraZeneca plc (ADR) (NYSE: AZN) shares are trading higher by $2.33 (8 percent) at $33.45 in Friday’s session.
The catalyst for the rally is the announcement that its drug, Imfinzi, has met primary endpoint for the treatment of lung cancer.
May 12, 2017 at 07:33PM
from Joel Elconin
No comments:
Post a Comment